153 related articles for article (PubMed ID: 3767385)
1. [Hepatic failure and renal failure in antineoplastic chemotherapy, and its treatment].
Nakao I
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2930-8. PubMed ID: 3767385
[TBL] [Abstract][Full Text] [Related]
2. Renal and metabolic toxicities of cancer chemotherapy.
Schilsky RL
Semin Oncol; 1982 Mar; 9(1):75-83. PubMed ID: 7200263
[TBL] [Abstract][Full Text] [Related]
3. Part I: Liver function in oncology: biochemistry and beyond.
Field KM; Dow C; Michael M
Lancet Oncol; 2008 Nov; 9(11):1092-101. PubMed ID: 19012858
[TBL] [Abstract][Full Text] [Related]
4. [Hepatotoxicity of chemotherapy].
Okamoto R; Maeda Y; Sasaki T
Nihon Rinsho; 2003 Jun; 61(6):978-83. PubMed ID: 12806946
[TBL] [Abstract][Full Text] [Related]
5. [Nephrotoxicity induced by chemotherapy].
Di Vito R; Sirolli V; Amoroso L; Bonomini M
G Ital Nefrol; 2011; 28(3):296-304. PubMed ID: 21626498
[TBL] [Abstract][Full Text] [Related]
6. End-stage renal disease following carboplatin chemotherapy for a nasopharyngeal carcinoma.
Tarrass F; Benmensour M; Bayla A
Ren Fail; 2007; 29(8):1049-51. PubMed ID: 18067055
[TBL] [Abstract][Full Text] [Related]
7. Hepatotoxicity of chemotherapy.
King PD; Perry MC
Oncologist; 2001; 6(2):162-76. PubMed ID: 11306728
[TBL] [Abstract][Full Text] [Related]
8. Onco-nephrology: renal toxicities of chemotherapeutic agents.
Perazella MA
Clin J Am Soc Nephrol; 2012 Oct; 7(10):1713-21. PubMed ID: 22879440
[TBL] [Abstract][Full Text] [Related]
9. Hepatotoxicity of chemotherapy.
Floyd J; Mirza I; Sachs B; Perry MC
Semin Oncol; 2006 Feb; 33(1):50-67. PubMed ID: 16473644
[TBL] [Abstract][Full Text] [Related]
10. Is hepatic infusion of chemotherapy effective treatment for liver metastases? Yes!
Kemeny NE
Important Adv Oncol; 1992; ():207-27. PubMed ID: 1533847
[No Abstract] [Full Text] [Related]
11. Adjunctive agents in systemic chemotherapy.
Lyman GH
Compr Ther; 1980 Oct; 6(10):16-25. PubMed ID: 6778649
[No Abstract] [Full Text] [Related]
12. Nephrotoxicity from chemotherapy: prevention and management.
Vogelzang NJ
Oncology (Williston Park); 1991 Oct; 5(10):97-102, 105; disc. 105, 109-11. PubMed ID: 1838278
[TBL] [Abstract][Full Text] [Related]
13. Assessment of renal function in the patient receiving chemotherapy.
Lydon J
Cancer Nurs; 1989 Jun; 12(3):133-43. PubMed ID: 2743296
[TBL] [Abstract][Full Text] [Related]
14. Renal toxicities of chemotherapy.
de Jonge MJ; Verweij J
Semin Oncol; 2006 Feb; 33(1):68-73. PubMed ID: 16473645
[TBL] [Abstract][Full Text] [Related]
15. Renal safety of gadolinium-based contrast media in patients with chronic renal insufficiency.
Ledneva E; Karie S; Launay-Vacher V; Janus N; Deray G
Radiology; 2009 Mar; 250(3):618-28. PubMed ID: 19244037
[TBL] [Abstract][Full Text] [Related]
16. [Kidney and urinary tract complications in tumor patients].
Joss R; Goldhirsch A; Brunner K
Schweiz Med Wochenschr; 1980 Mar; 110(11):390-404. PubMed ID: 6988956
[TBL] [Abstract][Full Text] [Related]
17. [Prevention and management of nephrotoxicity from anti-cancer agents].
Miyazaki J; Kawai K
Nihon Rinsho; 2003 Jun; 61(6):973-7. PubMed ID: 12806945
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin nephrotoxicity: experimental and clinical studies.
Daugaard G
Dan Med Bull; 1990 Feb; 37(1):1-12. PubMed ID: 2178884
[TBL] [Abstract][Full Text] [Related]
19. Tubulointerstitial injury associated with chemotherapeutic agents.
Shirali AC; Perazella MA
Adv Chronic Kidney Dis; 2014 Jan; 21(1):56-63. PubMed ID: 24359987
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy in the elderly: pharmacologic considerations.
Lichtman SM; Villani G
Cancer Control; 2000; 7(6):548-56. PubMed ID: 11088063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
